Home » Blog » Pfizer asks for formal US approval of oral COVID treatment Paxlovidon July 1, 2022 at 2:18 am on July 1, 2022 at 2:18 am

Pfizer asks for formal US approval of oral COVID treatment Paxlovidon July 1, 2022 at 2:18 am on July 1, 2022 at 2:18 am

Pfizer Inc said on Thursday it is seeking full US approval for its oral COVID-19 antiviral treatment Paxlovid, which is currently available under an emergency use authorization (EUA).Pfizer Inc said on Thursday it is seeking full US approval for its oral COVID-19 antiviral treatment Paxlovid, which is currently available under an emergency use authorization (EUA).Read More

Shopping Cart